BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8644327)

  • 1. Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Walecka-Zielecka B; Rancewicz Z; Rowińska D; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Feb; 28(1):50-1. PubMed ID: 8644327
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against HBV, HCV and HAV detected by using microparticle enzyme immunoassay in hepatitis outpatients.
    Boboş C; Spânu I; Bîlc AM
    Roum Arch Microbiol Immunol; 2006; 65(3-4):87-92. PubMed ID: 18389722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis A, B, C and E virus markers among patients with elevated levels of Alanine aminotransferase and Aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam)].
    Buchy P; Monchy D; An TT; Srey CT; Tri DV; Son S; Glaziou P; Chien BT
    Bull Soc Pathol Exot; 2004 Aug; 97(3):165-71. PubMed ID: 15462195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of anti-HCV(+) renal allograft recipients.
    Lee SW; Kang SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1501-2. PubMed ID: 8658759
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection in Italian kidney graft recipients. Changing risk factors and hepatitis C virus genotypes.
    Angelico M; Tisone G; Rapicetta M; Pisani F; Gandin C; Chionne P; Dettori S; Iaria G; Danese V; Orlando G; Casciani CU
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):448-55. PubMed ID: 9494855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A
    Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hepatitis B and hepatitis C virus infections on patients and allograft outcomes in renal transplant recipients: a single center study.
    Ghafari A; Sanadgol H
    Transplant Proc; 2008; 40(1):196-8. PubMed ID: 18261585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
    Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.